On Wednesday, Shares of Zoetis Inc. (NYSE:ZTS), dropped -1.07% to $47.03.
Zoetis, will take part in the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, in Las Vegas, Nev. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is planned to present at 6:00 p.m. EDT.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The company operates through four segments: the United States; Europe/Africa/Middle East; Canada/Latin America; and Asia/Pacific.
Shares of Transocean Ltd. (NYSE:RIG), declined -1.06% to $16.85, during its last trading session.
Transocean, declared that Jeremy D. Thigpen has been named President and Chief Executive Officer effective April 22, 2015. Mr. Thigpen succeeds Ian C. Strachan, Interim CEO. As formerly declared, Mr. Strachan, who is also the company`s Chairman of the Board of Directors, will retire from the Board at the end of his term at the 2015 Annual General Meeting following about 16 years of service.
Preceding to joining Transocean, Mr. Thigpen spent his career in various roles at National Oilwell Varco (“NOV”) and has served since 2012 as NOV`s Senior Vice President and Chief Financial Officer. Additionally, he was President of NOV`s Downhole and Pumping Solutions business from 2007 until 2012, and from 2003 to 2007 served as President of NOV`s Downhole Tools group. Mr. Thigpen joined National-Oilwell, Inc. in 1997 and, before being named President of Downhole Tools, served in various administration and business development capacities, counting Director of Business Development and Special Assistant to the Chairman. Mr. Thigpen earned a Bachelor of Arts, Economics and Managerial Studies from Rice University and accomplished the Program for Administration Development at Harvard Business School.
Transocean Ltd., together with its auxiliaries, provides offshore contract drilling services for oil and gas wells worldwide. The company primarily offers deepwater and harsh environment drilling services.
At the end of Wednesday’s trade, Shares of ACE Limited (NYSE:ACE), dwindled -1.05% to $107.86.
ACE Global Markets, the London-based wholesale insurance division of ACE Group, declared that it will offer raised capacity of up to US$100 million for clients seeking fine art and specie insurance coverage as client demand for this type of cover grows.
The ACE Global Markets fine art and specie team provides innovative insurance solutions for art, general specie, cash in transit and jeweler’s block for clients worldwide, underwritten through the London market. Recently, the team has been increasingly successful in marketing ACE’s multinational capabilities to brokers and clients and has designated a fifth specialist underwriter, Gemma Bartlett, to join its well-established London-based team in response to growing client demand.
ACE Limited, through its auxiliaries, provides a range of property and casualty insurance and reinsurance products worldwide. The company’s Insurance North American P&C segment offers casualty insurance, environmental, inland marine, professional risk, disaster protection, vacant land and building, and claims and risk administration services.
Finally, Mead Johnson Nutrition Company (NYSE:MJN), ended its last trade with -1% loss, and closed at $98.92.
Mead Johnson Nutrition Company, will release its first quarter 2015 earnings on Thursday, April 23, 2015, before the market opens. The company will host a conference call at 8:30 a.m. CDT that same day, during which company executives will review the financial results and respond to questions from analysts and investors.
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
